Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 16 min ago
Peer-reviewedCC BYClinical practice and cases in emergency medicine

Drug-Induced Immune Thrombocytopenia Caused by Sulfamethoxazole-Trimethoprim: A Case Report

  1. 1Baylor University Medical Center, Department of Emergency Medicine, Dallas, Texas

Abstract

Introduction: Drug-induced immune thrombocytopenia (DITP) is a rare process in which specific drugs induce antibodies against platelet antigens, resulting in the destruction, consumption, or impaired production of platelets.1,3 Sulfamethoxazole-trimethoprim can result in DITP.2

Case Report: This is a case of a 64-year-old man who developed severe thrombocytopenia after sulfamethoxazole-trimethoprim use. He presented to the emergency department with oral hemorrhagic lesions, mucositis, and petechiae. Laboratory evaluation revealed a low platelet count. Drug-induced immune thrombocytopenia was suspected, and the sulfamethoxazole-trimethoprim was discontinued. The patient’s platelet count responded rapidly after discontinuation of the offending drug and administration of dexamethasone.

Conclusion: This case highlights the importance of early recognition of DITP and the avoidance of re-exposure to the causative agent. Prompt drug withdrawal and adjunctive corticosteroid therapy can facilitate complete clinical recovery.

Related

  1. Complicated Urinary Tract Infections Caused by Fluoroquinolone-Non-Susceptible/Trimethoprim-Sulfamethoxazole-Resistant Extended-Spectrum β-Lactamase-Producing Enterobacterales: Patient Characteristics, Resistance Phenotypes, Treatment Patterns, and Clinical Outcomes
    Ryan K. Shields, A. Lenore Ackerman, Myriam Drysdale +9
    Infectious Diseases and TherapyPeer-reviewedCC BY-NC 4.0Full textInfectious diseasePMC
  2. Single-strength trimethoprim/sulfamethoxazole (TMP/SMX)-induced hypoglycaemia in a post kidney-pancreas transplant patient
    Naseeruddin Khan, Numair Khan, Irfan Agha +1
    BMJ Case ReportsPeer-reviewedCC BY-NC 4.0Full textSurgery & anaesthesiaPMC
  3. Disseminated Trimethoprim/Sulfamethoxazole–Resistant Nocardiosis in Renal Transplant Recipient, India
    Sandeep Rao Kordcal, Md Tariq Maula, Vivek Malleshappa Suguna +8
    Emerging Infectious DiseasesPeer-reviewedCC BY 4.0Full textInfectious diseaseDOAJPMC
  4. Evolutionary Convergence on a Dihydrofolate Reductase Mutation Drives Trimethoprim–Sulfamethoxazole Resistance in Burkholderia thailandensis
    Sophie Guillier, Christine Lazennec-Schurdevin, Lou Mondange +9
    ACS Infectious DiseasesPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthHAL
  5. Clinical Outcomes of Trimethoprim-Sulfamethoxazole with or Without Adjunctive Caspofungin in Patients with Moderate-to-Severe HIV-Associated Pneumocystis jirovecii Pneumonia: A Retrospective Cohort Study
    Yu Wang, Caopei Zheng, Yuqing Sun +1
    Infection and Drug ResistancePeer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthPMC
BibTeX
@article{powell2026druginduced,
  title = {{Drug-Induced Immune Thrombocytopenia Caused by Sulfamethoxazole-Trimethoprim: A Case Report}},
  author = {Alec Powell and Louisa Weindruch and Jonathan Thornton},
  journal = {Clinical practice and cases in emergency medicine},
  year = {2026},
  month = oct,
  doi = {10.5811/cpcem.65094},
  url = {https://europepmc.org/article/PMC/PMC13754471},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Drug-Induced Immune Thrombocytopenia Caused by Sulfamethoxazole-Trimethoprim: A Case Report
AU  - Alec Powell
AU  - Louisa Weindruch
AU  - Jonathan Thornton
PY  - 2026
DA  - 2026/10/30
JO  - Clinical practice and cases in emergency medicine
DO  - 10.5811/cpcem.65094
UR  - https://europepmc.org/article/PMC/PMC13754471
AB  - Introduction: Drug-induced immune thrombocytopenia (DITP) is a rare process in which specific drugs induce antibodies against platelet antigens, resulting in the destruction, consumption, or impaired production of platelets.1,3 Sulfamethoxazole-trimethoprim can result in DITP.2  Case Report: This is a case of a 64-year-old man who developed severe thrombocytopenia after sulfamethoxazole-trimethoprim use. He presented to the emergency department with oral hemorrhagic lesions, mucositis, and petechiae. Laboratory evaluation revealed a low platelet count. Drug-induced immune thrombocytopenia was suspected, and the sulfamethoxazole-trimethoprim was discontinued. The patient’s platelet count responded rapidly after discontinuation of the offending drug and administration of dexamethasone.  Conclusion: This case highlights the importance of early recognition of DITP and the avoidance of re-exposure to the causative agent. Prompt drug withdrawal and adjunctive corticosteroid therapy can facilitate complete clinical recovery.
SN  - 2474-252X
ER  -